← Back to Search

Behavioral Intervention

Behavioral Interventions for Type 2 Diabetes (COMMITTED2-KC Trial)

N/A
Waitlist Available
Led By Jared Bruce, PhD
Research Sponsored by University of Missouri, Kansas City
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18 to 65
Currently receiving treatment for diabetes by a licensed healthcare provider
Must not have
Diagnosis of a medical/psychiatric condition that would prevent participation in the study
Secondary type 2 diabetes
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 14 weeks
Awards & highlights

Summary

This trial is testing a program that combines diabetes coaching, financial rewards, and continuous glucose monitoring to see if it can help adults with type 2 diabetes better manage their condition. The study aims to determine

Who is the study for?
Adults with type 2 diabetes in Kansas City who are interested in improving their blood sugar management may qualify for this study. Participants should be willing to follow a diabetes treatment plan, use continuous glucose monitoring, and engage with coaching sessions.
What is being tested?
The trial is testing a program that combines continuous glucose monitoring with personalized coaching and financial incentives to see if it helps patients better stick to their diabetes treatment plans and manage their blood sugar levels.
What are the potential side effects?
Since the intervention involves behavioral changes rather than medication, side effects are minimal but could include potential stress or anxiety from lifestyle adjustments and the pressure of adhering to the treatment plan.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 65 years old.
Select...
I am currently being treated for diabetes by a healthcare professional.
Select...
I have been diagnosed with type 2 diabetes.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have any health or mental conditions that would stop me from joining the study.
Select...
I have type 2 diabetes.
Select...
I use short-acting insulin for my diabetes.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 14 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 14 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Hemoglobin A1C
Time in target blood glucose range per CGM
Secondary study objectives
Diabetes Distress Scale
Diabetes Quality of Life Brief Inventory
Motivation and Confidence Ruler
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Behavioral Intervention with financial rewards and coachingExperimental Treatment1 Intervention
Individuals in the treatment group will receive financial rewards (contingency management) and diabetes coaching (motivational interviewing) in addition to wearing a continuous glucose monitor while receiving their usual diabetes treatment.
Group II: ControlActive Control1 Intervention
Individuals in the control group will not receive any interventions and will only wear a continuous glucose monitor while receiving their usual diabetes treatment.

Find a Location

Who is running the clinical trial?

University of Missouri, Kansas CityLead Sponsor
71 Previous Clinical Trials
34,384 Total Patients Enrolled
Jared Bruce, PhDPrincipal InvestigatorUniversity of Missouri, Kansas City
4 Previous Clinical Trials
521 Total Patients Enrolled
~17 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top